1. Home
  2. BRNX vs EOCN Comparison

BRNX vs EOCN Comparison

Compare BRNX & EOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrenX Ltd. Ordinary Shares

BRNX

BrenX Ltd. Ordinary Shares

N/A

Current Price

$1.06

Market Cap

3.5M

Sector

N/A

ML Signal

N/A

EOCN

Eocene Ltd. Ordinary Shares

N/A

Current Price

$3.05

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRNX
EOCN
Founded
2012
2000
Country
Israel
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.6M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
BRNX
EOCN
Price
$1.06
$3.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 107.7K
6.0K
Earning Date
09-09-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35,081.65
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$2.67
52 Week High
$10.36
$3.80

Technical Indicators

Market Signals
Indicator
BRNX
EOCN
Relative Strength Index (RSI) 31.29 38.68
Support Level N/A N/A
Resistance Level $2.49 $3.80
Average True Range (ATR) 0.17 0.24
MACD -0.07 -0.06
Stochastic Oscillator 15.09 39.58

Price Performance

Historical Comparison
BRNX
EOCN

About BRNX BrenX Ltd. Ordinary Shares

BrenX Ltd is reshaping industrial energy to make it cleaner, more reliable, and lower cost. Building on its proprietary bGen thermal energy storage technology, which converts electricity and recovered heat into dispatchable energy, BrenX develops, owns, operates, and optimizes energy assets that serve industrial customers and data centers. From local generation and storage to grid connectivity and intelligent energy management, BrenX brings together technologies and infrastructure to create complete energy platforms around customer needs, with flexible energy assets designed to meet growing energy demand.

About EOCN Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.

Share on Social Networks: